# Individual Patient Expanded Access Gilteritinib (ASP2215)

> **NCT03315299** · — · NO_LONGER_AVAILABLE · sponsor: **Etan Orgel**

## Conditions studied

- AML

## Interventions

- **DRUG:** ASP2215

## Key facts

- **NCT ID:** NCT03315299
- **Lead sponsor:** Etan Orgel
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** NO_LONGER_AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2024-02-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03315299

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03315299, "Individual Patient Expanded Access Gilteritinib (ASP2215)". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03315299. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*